Stay updated on BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial page.

Latest updates to the BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedMinor revision bump from v3.3.1 to v3.3.2 with no observable content or layout changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page shows a new revision entry (v3.3.1) and removal of the previous revision (v3.2.0) in the revision history. This is a metadata update and does not affect the study details or user-facing content.SummaryDifference0.1%

- Check27 days agoChange DetectedThe funding-status notice has been removed from the page, which is an administrative display change and does not affect core trial content such as eligibility, endpoints, or locations.SummaryDifference0.4%

- Check41 days agoChange DetectedMinor editorial and formatting adjustments observed; core study details, outcomes, and eligibility criteria appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check70 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%

- Check77 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, indicating a new release. No other content changes are indicated.SummaryDifference0.1%

Stay in the know with updates to BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 Combo with Nivolumab in Chinese Patients Clinical Trial page.